For example, the angiotensin II type 1 receptor blocker losartan inhibits fibrosis and improves the disease in mouse models for Duchenne muscular dystrophy and LAMA2 MD [5–7]. This evidence concerns the gene LAMA2 and Duchenne muscular dystrophy.